Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 1
2010 3
2011 1
2012 2
2013 2
2017 3
2018 3
2019 3
2020 3
2021 5
2022 4
2023 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB, Huikuri HV, Johansson I, Jüni P, Lettino M, Marx N, Mellbin LG, Östgren CJ, Rocca B, Roffi M, Sattar N, Seferović PM, Sousa-Uva M, Valensi P, Wheeler DC; ESC Scientific Document Group. Cosentino F, et al. Among authors: mellbin lg. Eur Heart J. 2020 Jan 7;41(2):255-323. doi: 10.1093/eurheartj/ehz486. Eur Heart J. 2020. PMID: 31497854 Review. No abstract available.
Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis.
Rossing P, Bain SC, Bosch-Traberg H, Sokareva E, Heerspink HJL, Rasmussen S, Mellbin LG. Rossing P, et al. Among authors: mellbin lg. Cardiovasc Diabetol. 2023 Aug 24;22(1):220. doi: 10.1186/s12933-023-01949-7. Cardiovasc Diabetol. 2023. PMID: 37620807 Free PMC article.
Diabetes, prediabetes and cardiovascular risk.
Mellbin LG, Anselmino M, Rydén L. Mellbin LG, et al. Eur J Cardiovasc Prev Rehabil. 2010 May;17 Suppl 1:S9-14. doi: 10.1097/01.hjr.0000368192.24732.2f. Eur J Cardiovasc Prev Rehabil. 2010. PMID: 20489420 Review.
Effect of dipeptidyl peptidase-4 inhibitors on complement activation.
Hoffmann-Petersen IT, Holt CB, Jensen L, Hage C, Mellbin LG, Thiel S, Hansen TK, Østergaard JA. Hoffmann-Petersen IT, et al. Among authors: mellbin lg. Diabetes Metab Res Rev. 2021 Mar;37(3):e3385. doi: 10.1002/dmrr.3385. Epub 2020 Aug 18. Diabetes Metab Res Rev. 2021. PMID: 32662092 Clinical Trial.
Copeptin is associated with mortality in elderly people.
Smaradottir MI, Andersen K, Gudnason V, Näsman P, Rydén L, Mellbin LG. Smaradottir MI, et al. Among authors: mellbin lg. Eur J Clin Invest. 2021 Jul;51(7):e13516. doi: 10.1111/eci.13516. Epub 2021 Feb 18. Eur J Clin Invest. 2021. PMID: 33569762
30 results